BioNTech - HealthQuill - Page 2

About Us

Bharti Rana Jayshankar – Founder

She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.

Jay Shankar – Co-founder

He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.

Contact Info

info@healthquill.com

mosquito

Drugs Health Pharma

BioNTech begins trials for mRNA malaria vaccine

BioNTech company starts trial for mRNA based malaria vaccine

by HealthQuill
December 23, 2022
0 Comments

Read More

Covid-19

Drugs Pharma

Pfizer, BioNTech start trial on one vaccine to prevent both Covid-19, influenza

HQ Team November 4, 2022: The US-based drugmaker Pfizer Inc and Germany’s BioNTech have started clinical trials for a vaccine to prevent both.

by HealthQuill
November 4, 2022
0 Comments

Read More

BioNTech signs pact with Australia

Pharma

COVID-19 vaccine maker BioNTech inks research deal with Australia

COVID-19 vaccine maker BioNTech inks research deal with Australia

by HealthQuill
October 8, 2022
0 Comments

Read More

1
2